Novartis Hopes For Canakinumab In Lung Cancer Nosedive

Second Phase III Fail In NSCLC

 
• By Kevin Grogan
  
Canopy
Novartis canopy program needs patching up • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas